Three Key Trends in the Solubility Enhancement Industry
With approximately 90% of the active pharmaceutical ingredients that are under development falling into the two low solubility classes of the Biopharmaceutical Classification System (BCS), solubility enhancement technologies represent a strongly growing need for the pharmaceutical industry globally. Our current research covering solubility enhancement technologies and the related excipients market forecasts a compound annual growth